Valentine Capital Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Valentine Capital Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$3.93M	Sell	55,991 -10,890	-16%	-$743K	4.39%	3
2015 Q3	$4.16M	Buy	66,881 +25,061	+60%	+$1.97M	3.68%	2
2015 Q2	$3.52M	Sell	41,820 -36,060	-46%	-$2.8M	2.36%	8
2015 Q1	$5.85M	Sell	77,880 -19,335	-20%	-$1.35M	1.71%	14
2014 Q4	$6.04M	Sell	97,215 -24,090	-20%	-$1.37M	1.47%	22
2014 Q3	$6.31M	Sell	121,305 -4,410	-4%	-$225K	2.43%	15
2014 Q2	$6.45M	Sell	125,715 -5,100	-4%	-$230K	1.24%	24
2014 Q1	$6.21M	Buy	130,815 +34,710	+36%	+$1.78M	1.29%	26
2013 Q4	$4.17M	Buy	96,105 +10,260	+12%	+$425K	0.89%	53
2013 Q3	$3.7M	Buy	85,845 +4,140	+5%	+$168K	0.97%	42
2013 Q2	$2.84M	Buy	+81,705	New	+$2.87M	0.89%	44

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Valentine Capital Asset Management's XBI Position: Q4 2015 in Review

Valentine Capital Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 16% in Q4 2015, selling an estimated $743K and leaving 55,991 shares worth $3.93M. The position accounts for 4.39% of the portfolio, ranked #3.

Valentine Capital Asset Management first reported a position in XBI in Q2 2013 and has held it in 11 quarters since. The position peaked at $6.45M in Q2 2014. 199 funds tracked by Wall St. Rank hold XBI as of Q4 2015.

Valentine Capital Asset Management held 55,991 shares of State Street SPDR S&P Biotech ETF worth $3.93M as of Q4 2015.
Valentine Capital Asset Management sold 10,890 State Street SPDR S&P Biotech ETF shares in Q4 2015, an estimated $743K.
State Street SPDR S&P Biotech ETF made up 4.39% of Valentine Capital Asset Management's portfolio in Q4 2015, its #3 holding.
Valentine Capital Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 11 quarters since.
Valentine Capital Asset Management's State Street SPDR S&P Biotech ETF position peaked at $6.45M in Q2 2014.
199 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2015.

Based on Valentine Capital Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.